This inventor holds 2 USPTO granted patents. Top assignee: Novozymes A/s. Active years: 2004-2006.
Location History:
- Copenhagen, DK (2004)
- København, DK (2006)
Company Filing History:
Years Active: 2004-2006
Title: Fiona Duffner: Innovator in Gene Library Technologies
Introduction
Fiona Duffner is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of methods for gene library generation and screening. With a total of 2 patents, her work has the potential to impact various industrial applications.
Latest Patents
Fiona's latest patents include innovative methods that enhance the screening of gene libraries. One of her notable inventions, "Signal sequence trapping," allows for the identification of genes encoding secreted, partially secreted, or cell surface-displayed polypeptides of industrial interest. This invention addresses the limitations of conventional screening assays by enabling the detection of polypeptides such as enzymes, receptors, cytokines, and peptide hormones that may have been overlooked previously. Another significant patent is a "Method for generating a gene library," which focuses on creating a gene library enriched in DNA encoding polypeptides with specific activities from an environmental pool of organisms. This method not only facilitates the selection of DNA sequences of interest but also contributes to the advancement of gene library technologies.
Career Highlights
Fiona Duffner is currently employed at Novozymes A/S, a leading company in the biotechnology sector. Her role involves leveraging her expertise in gene technology to drive innovation and research within the organization.
Collaborations
Fiona has collaborated with notable colleagues, including Thomas Schäfer and Kirk Matthew Schnorr, to further enhance her research and development efforts.
Conclusion
Fiona Duffner's contributions to gene library technologies exemplify her innovative spirit and dedication to advancing biotechnology. Her patents reflect a commitment to addressing industrial challenges through scientific discovery.